Previous Page  58 / 63 Next Page
Information
Show Menu
Previous Page 58 / 63 Next Page
Page Background

Is there a role for surgery in stage IIIA NSCLC when there

is N2 disease?

§

It is clear that a subset of patients benefits from

surgery

§

However,

in part because of the heterogeneity of the

disease

,

identification

of such patients has been

extremely challenging

§

It is paramount

to involve the surgery team

in the

initial evaluation

§

surgery should be done in high-volume centers

§

thoracic surgeons

§

These factors have been associated with improved survival

Jeremic B Clin Lung cancer 2016; Albain K, Lancet 2009; Farjah F Ann Thorac Surg 2009